Amarin Corp Plcuk (AMRN) Current Assets (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Current Assets of $626.0 million for Q1 2026, up 9.24% year-over-year from $573.1 million in Q1 2025, and down 3.67% quarter-over-quarter from $649.9 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Current Assets (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Current Assets data on file, last reported at $626.0 million in Q1 2026.

  • Current Assets for Q1 2026 came in at $626.0 million, up 9.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $626.0 million (up 9.24% YoY), and the FY2025 annual result was $649.9 million, up 9.15% from the prior year.
  • Current Assets slipped to $626.0 million in Q1 2026 per AMRN's latest filing, from $649.9 million in the prior quarter.
  • Over five years, Current Assets peaked at $772.6 million in Q1 2022 and troughed at $573.1 million in Q1 2025.
  • A 5-year average of $671.7 million and a median of $686.5 million in 2022 frame the typical range for Current Assets.
  • The sharpest annual moves came in 2022 and 2026: Current Assets fell 28.71% in 2022, then rose 9.24% in 2026.
  • A 5-year view of Current Assets shows it stood at $689.1 million in 2022, then increased by 5.21% to $725.0 million in 2023, then declined by 17.87% to $595.4 million in 2024, then grew by 9.15% to $649.9 million in 2025, then retreated by 3.67% to $626.0 million in 2026.
  • Business Quant data shows AMRN's Current Assets at $626.0 million in Q1 2026, $649.9 million in Q4 2025, and $628.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 23.94 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 54.84 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 59.17 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 33.53 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 35.02 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 31.48 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 18.64 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 42.82 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 27.21 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn 626.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 626.00 Mn
Dec 31, 2025 649.88 Mn
Sep 30, 2025 628.30 Mn
Jun 30, 2025 606.80 Mn
Mar 31, 2025 573.06 Mn
Dec 31, 2024 595.40 Mn
Sep 30, 2024 650.22 Mn
Jun 30, 2024 701.80 Mn
Mar 31, 2024 687.90 Mn
Dec 31, 2023 724.98 Mn
Sep 30, 2023 717.51 Mn
Jun 30, 2023 706.50 Mn
Mar 31, 2023 683.80 Mn
Dec 31, 2022 689.10 Mn
Sep 30, 2022 686.52 Mn
Jun 30, 2022 719.10 Mn
Mar 31, 2022 772.62 Mn
Dec 31, 2021 878.73 Mn
Sep 30, 2021 963.03 Mn
Jun 30, 2021 996.00 Mn